Patton Fund Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-679
Closed -$239K 104
2026
Q1
$239K Hold
679
0.04% 337
2025
Q4
$222K Sell
679
-104
-13% -$33K 0.03% 335
2025
Q3
$221K Hold
783
0.04% 379
2025
Q2
$219K Buy
+783
New +$222K 0.05% 397
2024
Q4
Sell
-11,430
Closed -$3.68M 78
2024
Q3
$3.68M Sell
11,430
-619
-5% -$202K 0.76% 66
2024
Q2
$3.76M Sell
12,049
-2,532
-17% -$744K 0.79% 64
2024
Q1
$4.15M Buy
+14,581
New +$4.27M 0.75% 68
2023
Q1
Sell
-10,203
Closed -$2.68M 93
2022
Q4
$2.68M Buy
+10,203
New +$2.74M 0.78% 33

Other funds holding AMGN

Patton Fund Management's AMGN Position: Q2 2026 in Review

Patton Fund Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 679 shares — an estimated $239K sold.

Patton Fund Management first reported a position in AMGN in Q4 2022 and held it in 8 quarters. The position peaked at $4.15M in Q1 2024. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Patton Fund Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 679 Amgen shares in Q2 2026, an estimated $239K.
  • Patton Fund Management first reported a position in Amgen in Q4 2022 and held it in 8 quarters.
  • Patton Fund Management's Amgen position peaked at $4.15M in Q1 2024.
  • 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.